Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 25, 2006
Grant Date -
Jul 31, 2003
app pub date -
Jul 3, 2001
filing date -
Jul 6, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A purine nucleoside analog includes a pyrido[2,3-d]pyrimidine or a pyrimido[4,5-d]pyrimidine and further has a sugar moiety that is optionally modified at the C2', C3', C4' and/or C5' position. Particularly contemplated compounds also include prodrug forms of the purine nucleoside analogs, and both purine nucleoside analogs and the corresponding prodrugs are employed in the reduction of growth of neoplastic cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully